Lilly’s retatrutide outperformed on blood sugar control and weight loss in a phase 3 diabetes trial. US submission is planned ...
Once-weekly retatrutide induced greater declines in HbA1c and body weight than Ozempic 2 mg for adults with type 2 diabetes, ...
While many are aware of terms like "Ozempic face" and "Ozempic butt," people are discovering another "side effect" of GLP-1 ...
Eli Lilly raised its full-year revenue forecast and beat third-quarter profit estimates on Thursday, as booming demand for ...
Eli Lilly and Co. LLY shares are trending on Wednesday night. Shares of the Indiana-based pharmaceutical company gained 1.89% ...
The ‘triple G’ experimental drug also led to greater reductions in A1C. Drugmaker Lilly is expected to apply for FDA approval ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results